Literature DB >> 23312744

Early bactericidal activity of new drug regimens for tuberculosis.

Robert S Wallis, Carol Nacy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23312744     DOI： 10.1016/S0140-6736(13)60041-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Modeling and Simulation of Pretomanid Pharmacodynamics in Pulmonary Tuberculosis Patients.

Authors:  Michael A Lyons
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

2.  Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis.

Authors:  Robert S Wallis; Rodney Dawson; Sven O Friedrich; Amour Venter; Darcy Paige; Tong Zhu; Annette Silvia; Jason Gobey; Craig Ellery; Yao Zhang; Kathleen Eisenach; Paul Miller; Andreas H Diacon
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

3.  A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).

Authors:  Patrick P J Phillips; Kelly E Dooley; Stephen H Gillespie; Norbert Heinrich; Jason E Stout; Payam Nahid; Andreas H Diacon; Rob E Aarnoutse; Gibson S Kibiki; Martin J Boeree; Michael Hoelscher
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.